Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George R Stark

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
The Journal of Biological Chemistry|April 20, 2006
Hdm2 nuclear export, regulated by insulin-like growth factor-I/MAPK/p90Rsk signaling, mediates the transformation of human cellsMark W Jackson, Linnea E Patt, Gretchen A LaRusch, et al.
Molecular Cancer Therapeutics|July 17, 2014
Quinacrine overcomes resistance to erlotinib by inhibiting FACT, NF-κB, and cell-cycle progression in non-small cell lung cancerJosephine Kam Tai Dermawan, Katerina Gurova, John Pink, et al.
Experimental Dermatology|June 13, 2023
Topical N-phosphonacetyl-l-aspartate is a dual action candidate for treating non-melanoma skin cancerKala K Mahen, Lilian Markley, Jolie Bogart, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2004
Inhibitor of kappaB kinase is required to activate a subset of interferon gamma-stimulated genesNywana Sizemore, Anju Agarwal, Kingshuk Das, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2018
TRAF4 binds to the juxtamembrane region of EGFR directly and promotes kinase activationGang Cai, Liang Zhu, Xing Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2004
Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cellsTao Lu, Lyudmila G Burdelya, Shannon M Swiatkowski, et al.
Human Molecular Genetics|June 27, 2020
Germline PTEN mutations are associated with a skewed peripheral immune repertoire in humans and miceRitika Jaini, Matthew G Loya, Alexander T King, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65Tao Lu, Mark W Jackson, Benlian Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2010
Major differences in the responses of primary human leukocyte subsets to IFN-betaAnette H H van Boxel-Dezaire, Joana A Zula, Yaomin Xu, et al.
Nature Reviews. Drug Discovery|December 1, 2007
Interferons at age 50: past, current and future impact on biomedicineErnest C Borden, Ganes C Sen, Gilles Uze, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
The Journal of Biological Chemistry|April 20, 2006
Hdm2 nuclear export, regulated by insulin-like growth factor-I/MAPK/p90Rsk signaling, mediates the transformation of human cellsMark W Jackson, Linnea E Patt, Gretchen A LaRusch, et al.
Molecular Cancer Therapeutics|July 17, 2014
Quinacrine overcomes resistance to erlotinib by inhibiting FACT, NF-κB, and cell-cycle progression in non-small cell lung cancerJosephine Kam Tai Dermawan, Katerina Gurova, John Pink, et al.
Experimental Dermatology|June 13, 2023
Topical N-phosphonacetyl-l-aspartate is a dual action candidate for treating non-melanoma skin cancerKala K Mahen, Lilian Markley, Jolie Bogart, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2004
Inhibitor of kappaB kinase is required to activate a subset of interferon gamma-stimulated genesNywana Sizemore, Anju Agarwal, Kingshuk Das, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2018
TRAF4 binds to the juxtamembrane region of EGFR directly and promotes kinase activationGang Cai, Liang Zhu, Xing Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2004
Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cellsTao Lu, Lyudmila G Burdelya, Shannon M Swiatkowski, et al.
Human Molecular Genetics|June 27, 2020
Germline PTEN mutations are associated with a skewed peripheral immune repertoire in humans and miceRitika Jaini, Matthew G Loya, Alexander T King, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65Tao Lu, Mark W Jackson, Benlian Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2010
Major differences in the responses of primary human leukocyte subsets to IFN-betaAnette H H van Boxel-Dezaire, Joana A Zula, Yaomin Xu, et al.
Nature Reviews. Drug Discovery|December 1, 2007
Interferons at age 50: past, current and future impact on biomedicineErnest C Borden, Ganes C Sen, Gilles Uze, et al.
Pageof 13